Stock listing
A3ENQ5 Stock Price, News, Filings & Events — Schott Pharma Ag & Co. Kgaa
Selected listing: A3ENQ5 · LS · EUR · DE
This page tracks Schott Pharma Ag & Co. Kgaa's A3ENQ5:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ENQ5:LS. A3ENQ5:LS is the stock-level entry point for investors researching Schott Pharma Ag & Co. Kgaa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3ENQ5:LS
- Asset type
- Stock
- Market cap
- $4.08B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- LS
- Currency
- EUR
Schott Pharma Ag & Co. Kgaa A3ENQ5:LS stock context
This page tracks Schott Pharma Ag & Co. Kgaa's A3ENQ5:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3ENQ5:LS. A3ENQ5:LS is the stock-level entry point for investors researching Schott Pharma Ag & Co. Kgaa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Schott Pharma Ag & Co. Kgaa
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma publishes preliminary Q3 key figures and raises 2026 revenue and earnings guidance
July 8, 2026
Strengthening U.S. Pharmaceutical Supply: SCHOTT Pharma Inaugurates Expanded Vial Production in Lebanon, PA
June 3, 2026
SCHOTT Pharma : Financial Factsheet Q2 & H1 2026
May 13, 2026
SCHOTT Pharma mit robustem erstem Halbjahr und starkem Cashflow
May 13, 2026
SCHOTT Pharma : Quarterly statement Q1 2026
February 11, 2026
Research Schott Pharma Ag & Co. Kgaa
Schott Pharma Ag & Co. Kgaa investor report
Review AI stock analysis and investor report context for A3ENQ5:LS.
Schott Pharma Ag & Co. Kgaa company profile
View the public company page for Schott Pharma Ag & Co. Kgaa on 6ix.
Schott Pharma Ag & Co. Kgaa news
Read company news and market updates connected to Schott Pharma Ag & Co. Kgaa.
Schott Pharma Ag & Co. Kgaa investor events
Find investor webinars, events, and replay context for Schott Pharma Ag & Co. Kgaa.
Alternate listings
1SXP:XETR
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:GETTEX
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:TRADEGATE
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:MIL
IT · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
A3ENQ5:LSX
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:FWB
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:SWB
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:DUS
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
STTPF:OTC
US · USD
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXPD:AQUISUK
GB · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXPD:AQUISEU
GB · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.
1SXP:HAM
DE · EUR
Alternate listing for Schott Pharma Ag & Co. Kgaa; the primary context on this page is A3ENQ5:LS.